Your body accumulates tirzepatide levels over the first four to five weeks of treatment, reaching a steady state where the medication's glucose-lowering and weight-reduction effects plateau
This can cause a glutathione deficiency and a systemic immune reaction
You can contact NCIs Cancer Information Service via chat, email, or phone (both in English and Spanish) for help finding a doctor, hospital, or getting a second opinion
Frequency: Once per day (subcutaneous), 3060 minutes before bedtime
It also avoids GIP receptor agonism, whose metabolic consequences remain somewhat controversial (GIP has been characterized as both insulinotropic and adipogenic depending on context)
The sooner they can catch any issues, the sooner they can recommend lifestyle changes and treatments to reduce your risk